Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$101.21 - $166.61 $178,129 - $293,233
1,760 New
1,760 $209,000
Q2 2022

Jul 29, 2022

SELL
$117.13 - $176.59 $7,027 - $10,595
-60 Reduced 3.3%
1,760 $251,000
Q1 2022

May 02, 2022

SELL
$126.46 - $235.05 $58,171 - $108,123
-460 Reduced 20.18%
1,820 $314,000
Q4 2021

Feb 07, 2022

SELL
$225.82 - $368.51 $175,010 - $285,595
-775 Reduced 25.37%
2,280 $579,000
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $333,959 - $729,127
1,505 Added 97.1%
3,055 $1.18 Million
Q2 2021

Aug 03, 2021

SELL
$129.91 - $234.98 $25,982 - $46,996
-200 Reduced 11.43%
1,550 $364,000
Q1 2021

Apr 28, 2021

BUY
$109.18 - $185.98 $191,065 - $325,465
1,750 New
1,750 $229,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.